Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study

David T Yeung, On Behalf of the ALLG, Naranie Shanmuganathan et al.|Blood|2018

Cited by 8